SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000217028-05-000010
Filing Date
2005-11-10
Accepted
2005-11-10 11:19:50
Documents
1
Period of Report
2005-11-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4404
  Complete submission text file 0000217028-05-000010.txt   7251
Mailing Address 300 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address 300 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 (908) 243-6000
AVENTIS INC (Reporting) CIK: 0000217028 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21291 | Film No.: 051192449
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Issuer) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3711 KENNETT PIKE SUITE 200 GREENVILLE DE 19807
Business Address 3711 KENNETT PIKE SUITE 200 GREENVILLE DE 19807 3027777222
AVENTIS HOLDINGS INC (Reporting) CIK: 0001267075 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21291 | Film No.: 051192448